Microchip Completes Radiation-Hardened Power MOSFET Family to MIL-PRF-19500/746 and Achieves JANSF 300 Krad Capability
GlobeNewswire· 2025-04-17 20:00
Designed for extreme environments and conditions, radiation-hardened MOSFETs are available from 100 Krad to 300 Krad Total Ionizing DoseCHANDLER, Ariz., April 17, 2025 (GLOBE NEWSWIRE) -- The JANS qualification represents the highest level of screening and acceptance requirements, ensuring the superior performance, quality and reliability of discrete semiconductors for aerospace, defense and spaceflight applications. Microchip Technology (Nasdaq: MCHP) today announces its completion of its family of radiati ...
Allegro MicroSystems to Announce Fourth Quarter and Fiscal Year 2025 Financial Results
GlobeNewswire· 2025-04-17 20:00
文章核心观点 Allegro MicroSystems公司计划于2025年5月8日市场开盘前发布2025财年第四季度及全年财报,随后公司高管将召开电话会议讨论业绩和业务展望 [1] 财报发布及会议安排 - 公司计划于2025年5月8日市场开盘前发布2025财年第四季度及全年财报 [1] - 总裁兼首席执行官Mike Doogue和执行副总裁兼首席财务官Derek D'Antilio将于美国东部时间5月8日上午8:30召开电话会议,讨论公司业绩和业务展望 [1] 会议参与信息 - 分析师和投资者可通过指定链接参与电话会议,拨入参会者需提前注册获取拨入号码和专用PIN [2] - 电话会议的直播和存档音频网络直播至少90天内可在公司网站investors.allegromicro.com的活动与演示部分访问 [2] 公司简介 - 公司利用超三十年磁传感和功率IC专业知识,推动汽车、清洁能源和工业自动化发展,提供提升效率、性能和可持续性的解决方案 [3] - 公司对质量的承诺推动各行业变革,巩固其在“汽车级”技术领域的先驱地位,助力客户取得成功 [3] 联系方式 - 公司投资者关系与企业传播副总裁Jalene Hoover,电话+1 512 751 6526,邮箱jhoover@allegromicro.com [4]
Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
GlobeNewswire· 2025-04-17 20:00
CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced that data on elraglusib in advanced salivary gland carcinoma will be presented in a poster session at the American Association for Cancer Research (AACR) ...
Doman Building Materials Group Ltd. to Issue First Quarter 2025 Financial Results May 8, 2025
GlobeNewswire· 2025-04-17 20:00
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX: DBM) is pleased to announce that it will report its first quarter 2025 financial results for the period ended March 31, 2025, after market hours on Thursday, May 8, 2025. The Company will host an analyst ca ...
Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer
GlobeNewswire· 2025-04-17 20:00
WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced the appointment of Steven Bloom as Chief Business Officer. Mr. Bloom brings more than 35 years of experience in the life sciences industry leading ...
Diamond Equity Research Releases Update Note on Zhibao Technology Inc. (NASDAQ: ZBAO)
Newsfilter· 2025-04-17 20:00
New York, NY, April 17, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Zhibao Technology Inc. (NASDAQ:ZBAO). The update note includes information on Zhibao Technology Inc.'s financial results, management commentary, recent developments, outlook, and risks. The update note is available below. Zhibao Technology Update Note April 2025 Highlights from the note include: ...
NowVertical Launches DataCatalyst on Microsoft Azure Marketplace, Unlocking Enterprise AI at Scale
GlobeNewswire· 2025-04-17 20:00
文章核心观点 - 领先的数据和AI解决方案提供商NowVertical Group Inc.宣布在微软Azure市场推出旗舰DataCatalyst解决方案,巩固其在企业AI、数据基础设施现代化和微软生态系统扩展方面的战略定位 [1] 公司动态 - 公司于2025年4月17日宣布在微软Azure市场推出旗舰DataCatalyst解决方案 [1] - 该方案是为应对AI采用的紧迫性而构建的即部署即用的Azure原生解决方案,可统一、丰富和运营企业数据,推动客户数据之旅 [2] - 方案能实现无缝、安全和实时的数据移动,将数据产品的价值实现时间最多缩短50%,并将集成成本最多降低30%,为生成式AI、自动化和实时分析奠定基础 [2] - 公司CEO表示开发DataCatalyst是为响应现实世界对AI支持的需求,该方案为客户提供安全且加速的途径来运营其AI投资,并从现有数据资产中实现可衡量的投资回报率 [3] - 此次发布基于公司2024年11月26日启动的创建微软卓越中心(COE)的战略计划,该全球团队由印度、拉丁美洲和英国的50多名认证Azure专业人员组成 [3] - 公司已为企业客户交付了50多个大型基于Azure的项目,帮助组织优化运营、降低成本并加速数据转型之旅 [3] 公司介绍 - 公司是一家全球数据和分析公司,帮助客户利用AI快速将数据转化为切实的商业价值 [4] - 公司提供全面的解决方案和服务,使客户能够快速挖掘数据的全部潜力,推动可衡量的成果并加速潜在投资回报 [4] - 企业使用公司的AI融合的第一方和第三方技术优化决策、提高运营效率并从数据中释放长期价值 [4] - 公司通过有机增长和战略收购实现发展 [4]
NXP Semiconductors Announces Conference Call to Review First Quarter 2025 Financial Results
GlobeNewswire· 2025-04-17 20:00
文章核心观点 NXP Semiconductors宣布将于2025年4月28日收盘后发布2025年第一季度财报,并于4月29日上午8点(美国东部夏令时)举行财报电话会议 [1] 财报发布及会议安排 - 公司将于2025年4月28日纳斯达克全球精选市场正常交易收盘后发布2025年第一季度财务结果 [1] - 公司将于2025年4月29日上午8点(美国东部夏令时)与金融界举行财报电话会议 [1] 会议参与方式 - 感兴趣的各方可预先注册网络直播或获取特定用户访问代码加入直播电话会议 [2] - 电话会议结束后不久,可通过网络直播按需收听回放 [2] 公司介绍 - NXP Semiconductors是汽车、工业与物联网、移动和通信基础设施市场创新解决方案的可靠合作伙伴 [3] - 公司采用“Brighter Together”方法,结合前沿技术和创新人才开发系统解决方案 [3] - 公司在30多个国家开展业务,2024年营收达126.1亿美元 [3] 联系方式 - 投资者联系Jeff Palmer,电话+1 408 205 0687,邮箱jeff.palmer@nxp.com [4] - 媒体联系Paige Iven,电话+1 817 975 0602,邮箱paige.iven@nxp.com [4]
Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
Newsfilter· 2025-04-17 20:00
WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report first quarter 2025 financial results and provide a business update on Tuesday, May 6, 2025 after the U.S. financial markets close. The Company will also host a conference call and webcast the same day at 4:30 p.m. ET. A live webcast of the call and the pres ...
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
Newsfilter· 2025-04-17 20:00
TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fir ...